Hep­ati­tis B vac­cine banned

China Daily (Hong Kong) - - SUNDAY NEWS -

Chi­nese au­thor­i­ties on Fri­day is­sued a cir­cu­lar to ban the use of the re­com­bi­nant hep­ati­tis B vac­cine pro­duced by the Shen­zhen-based BioKang­tai com­pany. The cir­cu­lar, jointly is­sued by the China Food and Drug Ad­min­is­tra­tion and the Na­tional Health and Fam­ily Plan­ning Com­mis­sion, said four in­fant deaths were re­ported in Hu­nan, Guang­dong and Sichuan prov­inces af­ter in­oc­u­la­tions us­ing the vac­cine. The CFDA and the NHFPC will carry out fur­ther in­ves­ti­ga­tions into the cases and an in­spec­tion of the com­pany, the cir­cu­lar said. China’s top health au­thor­ity on Fri­day told health de­part­ments at all lev­els to tighten su­per­vi­sion of new pneu­mo­nia and flu cases. Ac­cord­ing to the Na­tional Health and Fam­ily Plan­ning Com­mis­sion, on Wed­nes­day, Jiangxi prov­ince con­firmed a hu­man case of H10N8, a new strain of bird flu. The com­mis­sion also said Guang­dong prov­ince has re­ported six cases of H7N9 bird flu since Oc­to­ber, and Zhejiang prov­ince re­ported five in the sec­ond half of the year. The com­mis­sion urged lo­cal health au­thor­i­ties to make H7N9 preven­tion and con­trol a pri­or­ity, strengthen mon­i­tor­ing and step up med­i­cal treat­ments. Heavy haze will con­tinue to shroud some cities in Cen­tral and East China since no cold front is in sight to dis­perse it, the na­tional ob­ser­va­tory fore­cast on Satur­day. The south­ern parts of North China, some re­gions along the Yel­low and Huai rivers, and ar­eas south of the Yangtze River will likely ex­pe­ri­ence haze — with vis­i­bil­ity at less than 1,000 me­ters — un­til Dec 25, the Na­tional Me­te­o­ro­log­i­cal Center said.

Newspapers in English

Newspapers from China

© PressReader. All rights reserved.